Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for Osteoporosis in First-time Liver Transplant Recipients
NCT04231682Phase 2Withdrawn
- Sponsor
- Einstein Healthcare Network
- Start
- Jul 2020
- Primary completion
- Jan 2024
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of denosumab in osteoporosis, sponsored by Einstein Healthcare Network. Planned start Jul 2020; status: withdrawn.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04231682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04231682.